Skip to main content
. 2023 Apr 20;18(4):e0284496. doi: 10.1371/journal.pone.0284496

Table 3. Diagnosis prevalence of HD population according to sex.

Prevalences are reported at time of HD diagnosis, as well as for the entire span of the observed disease trajectories.

Chronic condition Male Female Total
Prevalence at t = 0 (time of HD diagnosis)
Heart disease 100.00 (406792) 100.00 (359804) 100.00 (766596)
Hypertension 64.97 (264306) 74.69 (268721) 69.53 (533027)
High cholesterol 32.50 (132213) 23.52 (84640) 28.29 (216853)
Allergies 14.51 (59013) 21.16 (76149) 17.63 (135162)
COPD 11.03 (44873) 12.08 (43462) 11.52 (88335)
Diabetes 11.66 (47426) 10.12 (36401) 10.93 (83827)
Depression 6.38 (25955) 12.30 (44255) 9.16 (70210)
Osteoporosis 4.13 (16800) 14.81 (53307) 9.14 (70107)
Stroke 8.81 (35834) 9.06 (32596) 8.93 (68430)
Cancer 6.87 (27934) 7.26 (26122) 7.05 (54056)
Osteoarthritis 5.70 (23193) 8.20 (29496) 6.87 (52689)
Back pain 5.26 (21409) 6.39 (23005) 5.79 (44414)
Dementia 1.39 (5665) 2.58 (9277) 1.95 (14942)
Schizophrenia 1.34 (5466) 1.92 (6926) 1.62 (12392)
Joint disease 1.34 (5455) 1.55 (5580) 1.44 (11035)
Lifetime prevalencea
Heart disease 100.00 (406792) 100.00 (359804) 100.00 (766596)
Hypertension 77.71 (316100) 85.11 (306224) 81.18 (622324)
High cholesterol 51.12 (207983) 37.94 (136502) 44.93 (344485)
Allergies 25.24 (102687) 32.99 (118701) 28.88 (221388)
COPD 25.07 (101975) 24.32 (87506) 24.72 (189481)
Osteoporosis 12.11 (49269) 33.35 (120002) 22.08 (169271)
Stroke 21.15 (86021) 22.12 (79606) 21.60 (165627)
Diabetes 22.74 (92519) 18.75 (67450) 20.87 (159969)
Depression 15.87 (64542) 25.33 (91156) 20.31 (155698)
Cancer 20.38 (82923) 17.92 (64485) 19.23 (147408)
Osteoarthritis 12.63 (51361) 16.47 (59268) 14.43 (110629)
Back pain 11.52 (46846) 13.43 (48332) 12.42 (95178)
Dementia 6.34 (25806) 10.25 (36890) 8.18 (62696)
Schizophrenia 3.56 (14462) 5.22 (18778) 4.34 (33240)
Joint disease 4.26 (17330) 3.73 (13436) 4.01 (30766)

Prevalence are reported as % (n).

aLifetime prevalence is to be understood in the sense that the HD diagnosed individual has been observed to obtain the diagnosis in the time period 1995–2015.